Mindfulness-based cognitive therapy: Evaluating current evidence and informing future research
Mindfulness-based cognitive therapy: Evaluating current evidence and informing future research
复制标题
DOI：
10.1037/0022-006x.75.6.1000
复制
发表时间：
2007-12-01
影响因子：
5.9
通讯作者：
Ernst, Edzard
中科院分区：
文献类型：
--
作者：
Coelho, Helen F.;Canter, Peter H.;Ernst, Edzard
正念认知疗法（MBCT）是最近开发的一种以班级为基础的计划，旨在防止重性抑郁症的复发或复发（Z。V. Segal，J. M. G.威廉姆斯，& J.蒂斯代尔，2002年）。虽然这方面的研究还处于起步阶段，但MBCT在临床有效性方面通常被认为是一种有前途的治疗方法。本综述的目的是概述有助于当前观点的证据，并评估这些证据的优点和缺点，为未来的研究提供信息。通过系统检索6个电子数据库和检索文章的参考文献列表，作者识别出4项相关研究：2项随机临床试验，1项基于其中1项试验子集的研究，以及1项非随机试验。作者评估了这些试验，并在未来研究的背景下讨论了方法学问题。目前的随机试验证据表明，对于有3次或3次以上抑郁发作的患者，MBCT对常规治疗有额外的益处。然而，由于对照组的性质，这些发现不能归因于MBCT特异性效应。进一步的研究是必要的，以澄清是否MBCT确实有任何具体的影响。
Mindfulness-based cognitive therapy (MBCT) is a recently developed class-based program designed to prevent relapse or recurrence of major depression (Z. V. Segal, J. M. G. Williams, & J. Teasdale, 2002). Although research in this area is in its infancy, MBCT is generally discussed as a promising therapy in terms of clinical effectiveness. The aim of this review was to outline the evidence that contributes to this current viewpoint and to evaluate the strengths and weaknesses of this evidence to inform future research. By systematically searching 6 electronic databases and the reference lists of retrieved articles, the authors identified 4 relevant studies: 2 randomized clinical trials, 1 study based on a subset of 1 of these trials, and 1 nonrandomized trial. The authors evaluated these trials and discussed methodological issues in the context of future research. The current evidence from the randomized trials suggests that, for patients with 3 or more previous depressive episodes, MBCT has an additive benefit to usual care. However, because of the nature of the control groups, these findings cannot be attributed to MBCT-specific effects. Further research is necessary to clarify whether MBCT does have any specific effects.